Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity.

Cancers (Basel) · 2021 · PMC8534243 · PMID 34680314

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

In compliance, ruthenium amounts we have found in tumour explants (about 15% of the total) after a 4-week therapy are quite significant, especially when related to tumours weights with respect to the whole mouse mass.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.